Kura Oncology, Inc.
KURA
$7.58
-$0.07-0.92%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.49% | -8.21% | -13.99% | -38.19% | -29.95% |
| Total Depreciation and Amortization | 1.27% | -2.51% | -0.12% | 2.02% | 5.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.00% | 10.35% | 11.18% | -4.15% | -17.09% |
| Change in Net Operating Assets | 4,237.40% | 2,563.24% | 3,559.97% | 78.93% | 1.87% |
| Cash from Operations | 180.79% | 180.72% | 207.61% | -44.49% | -41.90% |
| Capital Expenditure | -1,460.29% | -214.81% | -180.95% | 29.27% | 74.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6,912.97% | -17.96% | -743.04% | 148.35% | 87.43% |
| Cash from Investing | -6,389.27% | -18.43% | -753.02% | 148.08% | 86.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.59% | -97.45% | 62.92% | 29.25% | 26.63% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -97.59% | -97.45% | 62.92% | 19.80% | 17.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,032.89% | -32.42% | 1,392.07% | 133.35% | -139.94% |